Free Trial

CeriBell (CBLL) Competitors

CeriBell logo
$24.69 +1.58 (+6.84%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$24.69 0.00 (0.00%)
As of 02/21/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CBLL vs. WRBY, LIVN, ENOV, NVCR, TMDX, LMAT, TNDM, SLNO, CNMD, and CDRE

Should you be buying CeriBell stock or one of its competitors? The main competitors of CeriBell include Warby Parker (WRBY), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), TransMedics Group (TMDX), LeMaitre Vascular (LMAT), Tandem Diabetes Care (TNDM), Soleno Therapeutics (SLNO), CONMED (CNMD), and Cadre (CDRE). These companies are all part of the "medical equipment" industry.

CeriBell vs.

CeriBell (NASDAQ:CBLL) and Warby Parker (NYSE:WRBY) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, community ranking, risk, media sentiment and profitability.

CeriBell has a net margin of 0.00% compared to Warby Parker's net margin of -4.39%. CeriBell's return on equity of 0.00% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
CeriBellN/A N/A N/A
Warby Parker -4.39%-8.26%-4.37%

In the previous week, Warby Parker had 4 more articles in the media than CeriBell. MarketBeat recorded 9 mentions for Warby Parker and 5 mentions for CeriBell. Warby Parker's average media sentiment score of 0.49 beat CeriBell's score of 0.21 indicating that Warby Parker is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CeriBell
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Warby Parker
3 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Warby Parker received 32 more outperform votes than CeriBell when rated by MarketBeat users. However, 100.00% of users gave CeriBell an outperform vote while only 42.11% of users gave Warby Parker an outperform vote.

CompanyUnderperformOutperform
CeriBellOutperform Votes
8
100.00%
Underperform Votes
No Votes
Warby ParkerOutperform Votes
40
42.11%
Underperform Votes
55
57.89%

93.2% of Warby Parker shares are held by institutional investors. 26.6% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

CeriBell presently has a consensus target price of $32.60, suggesting a potential upside of 32.04%. Warby Parker has a consensus target price of $21.92, suggesting a potential downside of 8.76%. Given CeriBell's stronger consensus rating and higher possible upside, analysts plainly believe CeriBell is more favorable than Warby Parker.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CeriBell
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00
Warby Parker
1 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.50

CeriBell has higher earnings, but lower revenue than Warby Parker.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CeriBellN/AN/AN/AN/AN/A
Warby Parker$669.77M3.65-$63.20M-$0.27-89.00

Summary

Warby Parker beats CeriBell on 7 of the 13 factors compared between the two stocks.

Get CeriBell News Delivered to You Automatically

Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CBLL vs. The Competition

MetricCeriBellElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$827.90M$3.41B$5.84B$9.14B
Dividend YieldN/A1.64%4.75%3.86%
P/E RatioN/A16.9226.7919.19
Price / SalesN/A73.24435.4570.88
Price / CashN/A44.0938.0134.83
Price / BookN/A3.857.644.62
Net IncomeN/A$92.00M$3.19B$246.06M
7 Day Performance15.16%4.50%-2.12%-2.63%
1 Month Performance6.24%9.09%-0.45%-2.15%
1 Year PerformanceN/A12.27%16.26%12.88%

CeriBell Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CBLL
CeriBell
N/A$24.69
+6.8%
$32.60
+32.0%
N/A$827.90MN/A0.00N/ANews Coverage
High Trading Volume
WRBY
Warby Parker
2.5369 of 5 stars
$25.70
-2.7%
$21.77
-15.3%
+69.9%$2.61B$669.77M-95.193,491Upcoming Earnings
Analyst Forecast
LIVN
LivaNova
3.7044 of 5 stars
$47.68
+0.1%
$69.17
+45.1%
-15.6%$2.59B$1.15B113.522,900Upcoming Earnings
ENOV
Enovis
3.4525 of 5 stars
$43.89
+0.4%
$64.83
+47.7%
-33.0%$2.50B$1.71B-20.046,550Short Interest ↓
Positive News
NVCR
NovoCure
3.4767 of 5 stars
$22.48
+3.5%
$32.67
+45.3%
+44.9%$2.43B$509.34M-16.061,453Upcoming Earnings
News Coverage
TMDX
TransMedics Group
3.6176 of 5 stars
$72.18
+1.3%
$122.70
+70.0%
-15.2%$2.42B$241.62M76.79210News Coverage
Gap Up
LMAT
LeMaitre Vascular
2.0323 of 5 stars
$98.65
+1.7%
$94.63
-4.1%
+64.2%$2.22B$193.48M53.91490Positive News
TNDM
Tandem Diabetes Care
4.0733 of 5 stars
$33.47
+2.6%
$53.81
+60.8%
+24.0%$2.20B$747.72M-17.342,400Upcoming Earnings
Positive News
SLNO
Soleno Therapeutics
4.5359 of 5 stars
$49.17
-4.2%
$71.20
+44.8%
-5.1%$2.12BN/A-14.8130News Coverage
CNMD
CONMED
4.6526 of 5 stars
$63.05
-2.1%
$77.20
+22.4%
-25.0%$1.95B$1.31B14.874,000
CDRE
Cadre
2.8965 of 5 stars
$35.14
-1.6%
$39.67
+12.9%
-6.1%$1.43B$482.53M42.342,435

Related Companies and Tools


This page (NASDAQ:CBLL) was last updated on 2/23/2025 by MarketBeat.com Staff
From Our Partners